Patron Partners LLC acquired a new position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 524 shares of the biotechnology company’s stock, valued at approximately $209,000.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. GSA Capital Partners LLP grew its holdings in Axon Enterprise by 61.2% in the 3rd quarter. GSA Capital Partners LLP now owns 1,736 shares of the biotechnology company’s stock worth $694,000 after buying an additional 659 shares in the last quarter. Apollon Wealth Management LLC boosted its stake in Axon Enterprise by 11.3% during the 3rd quarter. Apollon Wealth Management LLC now owns 1,304 shares of the biotechnology company’s stock valued at $521,000 after purchasing an additional 132 shares in the last quarter. Versor Investments LP bought a new position in Axon Enterprise during the 3rd quarter valued at $651,000. Venturi Wealth Management LLC boosted its stake in Axon Enterprise by 14.7% during the 3rd quarter. Venturi Wealth Management LLC now owns 781 shares of the biotechnology company’s stock valued at $312,000 after purchasing an additional 100 shares in the last quarter. Finally, Jag Capital Management LLC boosted its stake in Axon Enterprise by 9.7% during the 3rd quarter. Jag Capital Management LLC now owns 56,086 shares of the biotechnology company’s stock valued at $22,412,000 after purchasing an additional 4,954 shares in the last quarter. 79.08% of the stock is owned by institutional investors.
Analysts Set New Price Targets
AXON has been the subject of a number of research reports. Craig Hallum increased their price target on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Bank of America assumed coverage on Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $380.00 price objective for the company. The Goldman Sachs Group lifted their target price on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Jefferies Financial Group assumed coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 target price on the stock. Finally, Barclays lifted their target price on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $427.83.
Axon Enterprise Price Performance
NASDAQ AXON opened at $616.14 on Tuesday. Axon Enterprise, Inc. has a fifty-two week low of $216.73 and a fifty-two week high of $624.84. The stock’s 50-day moving average is $419.18 and its two-hundred day moving average is $349.77. The firm has a market cap of $46.56 billion, a P/E ratio of 159.21, a price-to-earnings-growth ratio of 15.15 and a beta of 0.94. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52.
Insider Transactions at Axon Enterprise
In other Axon Enterprise news, Director Jeri Williams sold 110 shares of the business’s stock in a transaction on Monday, September 30th. The shares were sold at an average price of $400.00, for a total transaction of $44,000.00. Following the completion of the transaction, the director now owns 1,934 shares of the company’s stock, valued at $773,600. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Jeri Williams sold 110 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $400.00, for a total transaction of $44,000.00. Following the completion of the transaction, the director now directly owns 1,934 shares in the company, valued at $773,600. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 80,300 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the sale, the chief executive officer now owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 369,172 shares of company stock worth $136,270,842. 6.10% of the stock is owned by insiders.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
- Five stocks we like better than Axon Enterprise
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Lam Research Fueled by Unyielding AI Demand Growth
- Golden Cross Stocks: Pattern, Examples and Charts
- Generac: 5 Reasons to Buy This Stock Before Year’s End
- What is the Dow Jones Industrial Average (DJIA)?
- Top 2 CRM Stocks Positioned to Surge Higher With AI in 2025
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.